Indefinite Delivery Contract SPE2DX15D9352

This indefinite delivery contract (IDC) was awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler. The $499,999,999 IDC, valid through November 2026, enables the DLA to issue firm fixed-price delivery orders for a comprehensive range of pharmaceutical items, including branded and generic prescription drugs, over-the-counter medications, biologics, and medical consumables, to support the medical supply needs of military health facilities worldwide.

Under this IDC, DMS Pharmaceutical Group has received multiple delivery order awards, valued between $500 and $22,500, for the supply of a variety of pharmaceutical products and medical supplies to the TRICARE West program. These firm fixed-price delivery orders cover a wide range of medical needs, such as oncology treatments, contraceptives, auto-injectors, and specialized pharmaceutical products. The contracts are not associated with any set-aside designations, allowing DMS Pharmaceutical Group to leverage its woman-owned small business status to secure direct federal awards across multiple product categories and medical domains.